Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
61.99
+0.89 (1.46%)
At close: May 12, 2025, 4:00 PM
61.99
0.00 (0.00%)
After-hours: May 12, 2025, 4:00 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $2.00 billion as of May 12, 2025. Its market cap has increased by 84.20% in one year.
Market Cap
2.00B
Enterprise Value
1.86B
1-Year Change
84.20%
Ranking
Category
Stock Price
$61.99
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $2.00B, an increase of 1,284.19%. That is a compound annual growth rate of 138.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 1.97B | 1.23% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |